Literature DB >> 25899945

Inducible suicide vector systems for Trypanosoma cruzi.

Yanfen Ma1, Louis M Weiss2, Huan Huang3.   

Abstract

Chagas disease caused by Trypanosoma cruzi is a major neglected tropical parasitic disease. The pathogenesis of this infection remains disputable. There is no suitable vaccine for the prevention. Attenuated live vaccines can provide strong protection against infection; however, there are the concerns about latent infection or reversion to virulence in such attenuated strains. A method to induce T. cruzi death would provide a critical tool for research into the pathophysiological mechanisms and provide a novel design of safe live attenuated vaccines. We established effective inducible systems for T. cruzi employing the degradation domain based on the Escherichia coli dihydrofolate reductase (ecDHFR). The DHFR degradation domain (DDD) can be stabilized by trimethoprim-lactate and can be used to express detrimental or toxic proteins. T. cruzi lines with Alpha-toxin, Cecropin A and GFP under the control of DDD with a hemagglutinin tag (HA) were developed. Interestingly, amastigotes bearing GFP-DDDHA, Alpha-toxin-DDDHA, Cecropin A-DDDHA and DDDHA all resulted in inducible cell death with these fusions, indicating that DDDHA protein is also detrimental to amastigotes. Furthermore, these strains were attenuated in mouse experiments producing no pathological changes and inoculation with these DDDHA strains in mice provided strong protection against lethal wild type infection.
Copyright © 2015 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Chagas disease; Trypanosoma cruzi; Vaccine

Mesh:

Substances:

Year:  2015        PMID: 25899945     DOI: 10.1016/j.micinf.2015.04.003

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  6 in total

1.  Induction of Effective Immunity against Trypanosoma cruzi.

Authors:  Tere Williams; Ignacio Guerrero-Ros; Yanfen Ma; Fabiane Matos Dos Santos; Philipp E Scherer; Ruth Gordillo; Aline Horta; Fernando Macian; Louis M Weiss; Huan Huang
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

Review 2.  Developments in the management of Chagas cardiomyopathy.

Authors:  Herbert B Tanowitz; Fabiana S Machado; David C Spray; Joel M Friedman; Oren S Weiss; Jose N Lora; Jyothi Nagajyothi; Diego N Moraes; Nisha Jain Garg; Maria Carmo P Nunes; Antonio Luiz P Ribeiro
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-10-23

3.  Contagion 2.0.

Authors:  Sophia Häfner
Journal:  Microbes Infect       Date:  2015-07-02       Impact factor: 2.700

4.  Suicidal Leishmania.

Authors:  Lucie Podešvová; Tereza Leštinová; Eva Horáková; Julius Lukeš; Petr Volf; Vyacheslav Yurchenko
Journal:  Pathogens       Date:  2020-01-25

Review 5.  Discovery and Genetic Validation of Chemotherapeutic Targets for Chagas' Disease.

Authors:  Juan Felipe Osorio-Méndez; Ana María Cevallos
Journal:  Front Cell Infect Microbiol       Date:  2019-01-07       Impact factor: 5.293

6.  A CRISPR/Cas9-riboswitch-Based Method for Downregulation of Gene Expression in Trypanosoma cruzi.

Authors:  Noelia Lander; Teresa Cruz-Bustos; Roberto Docampo
Journal:  Front Cell Infect Microbiol       Date:  2020-02-27       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.